GSDMD and cancer: There are high binding peaks around the GSDMD-enh3 on the ChIP-Seq data in various cancer cell lines (HepG2, GM12878, PANC-1, and A549), indicating that there are potential enhancers upstream of GSDMD (Figure 3G).